Sex differences in responsiveness to the prescription opioid oxycodone in mice

Pharmacology Biochemistry and Behavior

Volumn 148, Issue , 2016, Pages 99-105

  Collins, Devon ^a   Reed, Brian ^a   Zhang, Yong ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Antinociception; Conditioned place preference; Corticosterone; Locomotor behavior; Oxycodone; Sex difference

Indexed keywords

CORTICOSTERONE; OXYCODONE; CYTOCHROME P450 3A; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG RESPONSE; FEMALE; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NOCICEPTION; NONHUMAN; OPEN FIELD TEST; PLACE PREFERENCE; PRESCRIPTION; PRIORITY JOURNAL; REWARD; SEX DIFFERENCE; ANIMAL; BLOOD; C57BL MOUSE; CONDITIONING; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; SEXUAL DEVELOPMENT;

ANALGESICS, OPIOID; ANIMALS; CONDITIONING (PSYCHOLOGY); CORTICOSTERONE; CYTOCHROME P-450 CYP3A; FEMALE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; OXYCODONE; SEX CHARACTERISTICS;

EID: 84976902226     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2016.06.006     Document Type: Article

References (53)

1. Back, S.E., Payne, R.L., Wahlquist, A.H., Carter, R.E., Stroud, Z., Haynes, L., Hillhouse, M., Brady, K.T., Ling, W., Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am. J. Drug Alcohol Abuse 37:5 (2011 Sep), 313–323 PubMed PMID: 21854273; PubMed Central PMCID: PMC3164783.
2. Baker, D.D., Jenkins, A.J., A comparison of methadone, oxycodone, and hydrocodone related deaths in Northeast Ohio. J. Anal. Toxicol. 32:2 (2008 Mar), 165–171 PubMed PMID: 18334101.
3. Bartok, R.E., Craft, R.M., Sex differences in opioid antinociception. J. Pharmacol. Exp. Ther. 282:2 (1997 Aug), 769–778.
4. Baumann, M.H., Elmer, G.I., Goldberg, S.R., Ambrosio, E., Differential neuroendocrine responsiveness to morphine in Lewis, Fischer 344, and ACI inbred rats. Brain Res. 858:2 (2000 Mar 10), 320–326.
5. Bernal, S.A., Morgan, M.M., Craft, R.M., PAG mu opioid receptor activation underlies sex differences in morphine antinociception. Behav. Brain Res. 177:1 (2007 Feb 12), 126–133.
6. Bodnar, R.J., Kest, B., Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: central mechanisms of action and roles of gonadal hormones. Horm. Behav. 58 (2010), 72–81.
7. Byers, S.L., Wiles, M.V., Dunn, S.L., Taft, R.A., Mouse estrous cycle identification tool and images. PLoS One, 7(4), 2012, e35538, 10.1371/journal.pone.0035538 Epub 2012 Apr 13.
8. Cataldo, G., Bernal, S., Markowitz, A., Ogawa, S., Ragnauth, A., Pfaff, D.W., Bodnar, R.J., Organizational manipulation of gonadal hormones and systemic morphine analgesia in female rats: effects of adult ovariectomy and estradiol replacement. Brain Res., 1059(1), 2005 Oct 12 13–9.
9. Centers for Disease Control and Prevention, Today's Heroin Epidemic., 2015, July 7 (Retrieved from) http://www.cdc.gov/vitalsigns/heroin/.
10. Centers for Disease Control and Prevention, Drug overdose deaths hit record numbers in 2014., 2015, December 18 (Retrieved from) http://www.cdc.gov/media/releases/2015/p1218-drug-overdose.html.
11. Chan, S., Edwards, S.R., Wyse, B.D., Smith, M.T., Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat. Clin. Exp. Pharmacol. Physiol. 35:3 (2008 Mar), 295–302.
12. Cheung, C., Yu, A.M., Chen, C.S., Krausz, K.W., Byrd, L.G., Feigenbaum, L., Edwards, R.J., Waxman, D.J., Gonzalez, F.J., Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice. J. Pharmacol. Exp. Ther. 316:3 (2006 Mar), 1328–1334.
13. Cicero, T.J., Ennis, T., Ogden, J., Meyer, E.R., Gender differences in the reinforcing properties of morphine. Pharmacol. Biochem. Behav. 65:1 (2000 Jan 1), 91–96.
14. Craft, R.M., Clark, J.L., Hart, S.P., Pinckney, M.K., Sex differences in locomotor effects of morphine in the rat. Pharmacol. Biochem. Behav. 85:4 (2006 Dec), 850–858.
15. Dahan, A., Kest, B., Waxman, A.R., Sarton, E., Sex-specific responses to opiates: animal and human studies. Anesth. Analg. 107:1 (2008), 83–95.
16. Emery, M.A., Bates, M.L., Wellman, P.J., Eitan, S., Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2/D3 dopamine receptors. Behav. Brain Res. 284 (2015 May 1), 37–41, 10.1016/j.bbr.2015.01.023 (Epub 2015 Jan 21).
17. Gandhi, M., Aweeka, F., Greenblatt, R.M., Blaschke, T.F., Sex differences in pharmacokinetics and pharmacodynamics. Annu. Rev. Pharmacol. Toxicol. 44 (2004), 499–523.
18. Gear, R., Gordon, N., Heller, P., Paul, S., Miaskowski, C., Levine, J., Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci. Lett. 205 (1996), 207–209.
19. Gear, R., Miaskowski, C., Gordon, N., Paul, S., Heller, P., Levine, J., Kappa-opioids produce significantly greater analgesia in women than in men. Nat. Med. 2 (1996), 1248–1250.
20. Hammer, R.P., Mu-opiate receptor binding in the medial preoptic area is cyclical and sexually dimorphic. Brain Res. 515:1–2 (1990 May 7), 187–192.
21. Hunt, C.M., Westerkam, W.R., Stave, G.M., Effect of age and gender on the activity of human hepatic CYP3A. Biochem. Pharmacol. 44:2 (1992 Jul 22), 275–283.
22. Hunt, C.M., Watkins, P.B., Saenger, P., Stave, G.M., Barlascini, N., Watlington, C.O., Wright, J.T. Jr., Guzelian, P.S., Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol. Clin. Pharmacol. Ther. 51:1 (1992 Jan), 18–23.
23. Jones, C.M., Frequency of prescription pain reliever nonmedical use: 2002–2003 and 2009–2010. Arch. Intern. Med. 172:16 (2012 Sep 10), 1265–1267 PubMed PMID: 22733257.
24. Karami, M., Zarrindast, M.R., Morphine sex-dependently induced place conditioning in adult Wistar rats. Eur. J. Pharmacol. 582:1–3 (2008 Mar 17), 78–87, 10.1016/j.ejphar.2007.12.010 (Epub 2007 Dec 23). PMID: 18191832.
25. Kashuba, A.D., Bertino, J.S. Jr., Rocci, M.L. Jr., Kulawy, R.W., Beck, D.J., Nafziger, A.N., Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam. Clin. Pharmacol. Ther. 64:3 (1998 Sep), 269–277.
26. Kepler, K.L., Kest, B., Kiefel, J.M., Cooper, M.L., Bodnar, R.J., Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol. Biochem. Behav. 34:1 (1989 Sep), 119–127.
27. Kest, B., Wilson, S.G., Mogil, J.S., Sex differences in supraspinal morphine analgesia are dependent on genotype. J. Pharmacol. Exp. Ther. 289:3 (1999 Jun), 1370–1375.
28. Kinirons, M.T., O'Shea, D., Kim, R.B., Groopman, J.D., Thummel, K.E., Wood, A.J., Wilkinson, G.R., Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. Clin. Pharmacol. Ther. 66:3 (1999 Sep), 224–231.
29. Koek, W., France, C.P., Javors, M.A., Morphine-induced motor stimulation, motor incoordination, and hypothermia in adolescent and adult mice. Psychopharmacology 219:4 (2012 Feb), 1027–1037, 10.1007/s00213-011-2432-z.
30. Krzanowska, E.K., Bodnar, R.J., Morphine antinociception elicited from the ventrolateral periaqueductal gray is sensitive to sex and gonadectomy differences in rats. Brain Res. 821:1 (1999 Mar 6), 224–230.
31. Krzanowska, E.K., Bodnar, R.J., Analysis of sex and gonadectomy differences in beta-endorphin antinociception elicited from the ventrolateral periaqueductal gray in rats. Eur. J. Pharmacol. 392:3 (2000), 157–161.
32. Lee, C.W., Ho, I.K., Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors. Mol. Pain, 9(1), 2013 Sep 8, 45 PubMed PMID: 24010861.
33. Malisch, J.L., Saltzman, W., Gomes, F.R., Rezende, E.L., Jeske, D.R., Garland, T. Jr., Baseline and stress-induced plasma corticosterone concentrations of mice selectively bred for high voluntary wheel running. Physiol. Biochem. Zool. 80:1 (2007 Jan–Feb), 146–156 (Epub 2006 Nov 13).
34. Maruta, T., Swanson, D.W., Finlayson, R.E., Drug abuse and dependency in patients with chronic pain. Mayo Clin. Proc. 54:4 (1979 Apr), 241–244.
35. Meert, T.F., Vermeirsch, H.A., A preclinical comparison between different opioids: antinociceptive versus adverse effects. Pharmacol. Biochem. Behav. 80:2 (2005 Feb), 309–326.
36. Milner, T.A., Burstein, S.R., Marrone, G.F., Khalid, S., Gonzalez, A.D., Williams, T.J., Schierberl, K.C., Torres-Reveron, A., Gonzales, K.L., McEwen, B.S., Waters, E.M., Stress differentially alters mu opioid receptor density and trafficking in parvalbumin-containing interneurons in the female and male rat hippocampus. Synapse 67:11 (2013 Nov), 757–772, 10.1002/syn.21683.
37. Minami, K., Hasegawa, M., Ito, H., Nakamura, A., Tomii, T., Matsumoto, M., Orita, S., Matsushima, S., Miyoshi, T., Masuno, K., Torii, M., Koike, K., Shimada, S., Kanemasa, T., Kihara, T., Narita, M., Suzuki, T., Kato, A., Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models. J. Pharmacol. Sci. 111:1 (2009 Sep), 60–72.
38. Narita, M., Nakamura, A., Ozaki, M., Imai, S., Miyoshi, K., Suzuki, M., Suzuki, T., Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine. Neuropsychopharmacology 33:5 (2008 Apr), 1097–1112.
39. Niikura, K., Ho, A., Kreek, M.J., Zhang, Y., Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice. Pharmacol. Biochem. Behav. 110 (2013 Sep), 112–116, 10.1016/j.pbb.2013.06.010.
40. Olmstead, M.C., Burns, L.H., Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats. Psychopharmacology 181:3 (2005 Sep), 576–581.
41. Ono, H., Nakamura, A., Kanemasa, T., Sakaguchi, G., Shinohara, S., Effect of estrogen on morphine- and oxycodone-induced antinociception in a female femur bone cancer pain model. Eur. J. Pharmacol. 773 (2016 Feb 15), 1–12, 10.1016/j.ejphar.2016.01.001 (Epub 2016 Jan 20).
42. Peckham, E.M., Traynor, J.R., Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J. Pharmacol. Exp. Ther. 316:3 (2006 Mar), 1195–1201 (Epub 2005 Nov 16).
43. Pöyhiä, R., Kalso, E.A., Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats. Pharmacol. Toxicol. 70:2 (1992 Feb), 125–130.
44. Sakuma, T., Endo, Y., Mashino, M., Kuroiwa, M., Ohara, A., Jarukamjorn, K., Nemoto, N., Regulation of the expression of two female-predominant CYP3A mRNAs (CYP3A41 and CYP3A44) in mouse liver by sex and growth hormones. Arch. Biochem. Biophys. 404:2 (2002 Aug 15), 234–242.
45. Rasmussen, S., Miller, M.M., Filipski, S.B., Tolwani, R.J., Cage change influences serum corticosterone and anxiety-like behaviors in the mouse. J. Am. Assoc. Lab. Anim. Sci. 50:4 (2011 Jul), 479–483.
46. Rutten, K., van der Kam, E.L., De Vry, J., Tzschentke, T.M., Critical evaluation of the use of extinction paradigms for the assessment of opioid-induced conditioned place preference in rats. Pharmacology 87:5–6 (2011), 286–296, 10.1159/000327680 (Epub 2011 May 17).
47. Schlussman, S.D., Zhang, Y., Hsu, N.M., Allen, J.M., Ho, A., Kreek, M.J., Heroin-induced locomotor activity and conditioned place preference in C57BL/6J and 129P3/J mice. Neurosci. Lett. 440:3 (2008 Aug 8), 284–288, 10.1016/j.neulet.2008.05.103.
48. Sithisarn, T., Bada, H.S., Dai, H., Reinhardt, C.R., Randall, D.C., Legan, S.J., Effects of perinatal oxycodone exposure on the response to CRH in late adolescent rats. Neurotoxicol. Teratol. 30:2 (2008 Mar–Apr), 118–124, 10.1016/j.ntt.2007.12.010 (Epub 2008 Jan 11).
49. Smith, G.W., Aubry, J.M., Dellu, F., Contarino, A., Bilezikjian, L.M., Gold, L.H., Chen, R., Marchuk, Y., Hauser, C., Bentley, C.A., Sawchenko, P.E., Koob, G.F., Vale, W., Lee, K.F., Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:6 (1998 Jun), 1093–1102.
50. Smith, H.S., Opioid metabolism. Mayo Clin. Proc. 84:7 (2009 Jul), 613–624, 10.1016/S0025-6196(11)60750-7.
51. Söderberg Löfdal, K.C., Andersson, M.L., Gustafsson, L.L., Cytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications. Drugs 73:6 (2013 May), 533–543, 10.1007/s40265-013-0036-0.
52. Stoffel, E.C., Ulibarri, C.M., Craft, R.M., Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats. Pain 103:3 (2003 Jun), 285–302.
53. Zhang, Y., Picetti, R., Butelman, E.R., Schlussman, S.D., Ho, A., Kreek, M.J., Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice. Neuropsychopharmacology 34:4 (2009 Mar), 912–922, 10.1038/npp.2008.134.